MDL | MFCD03861062 |
---|---|
Molecular Weight | 244.23 |
Molecular Formula | C11H9FN6 |
SMILES | NC1=NC=NC2=C1C(NC3=CC=C(F)C=C3)N=N2 |
MNK1 2.2 μM (IC 50 ) |
CGP57380 inhibits phosphorylation of eIF4E in cellular assays with IC 50 of about 3 μM. CGP57380 causes dephosphorylation of eIF4E, and induces a further increase in the cap-dependent reporter in 293 cells [1] . CGP57380 results in dose-dependent decreases in Ang II-stimulated phosphorylation of eIF4E, protein synthesis, and VSMC hypertrophy [2] . CGP57380 sensitizes wild-type cells for serum-withdrawal induced apoptosis in mouse embryo fibroblasts (MEFs) [3] . CGP57380 prevents the serial replating function of BC progenitors [4] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
CGP57380 (40 mg/kg/d i.p.) potently extinguishes the ability of BC CML cells to serially transplant-immunodeficient mice and function as LSCs [4] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 6 mg/mL ( 24.57 mM ; Need ultrasonic and warming)
H 2 O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 4.0945 mL | 20.4725 mL | 40.9450 mL |
5 mM | 0.8189 mL | 4.0945 mL | 8.1890 mL |
10 mM | 0.4095 mL | 2.0473 mL | 4.0945 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution